HK1029125A1 - Dolastatin 15 derivatives - Google Patents

Dolastatin 15 derivatives

Info

Publication number
HK1029125A1
HK1029125A1 HK00108461A HK00108461A HK1029125A1 HK 1029125 A1 HK1029125 A1 HK 1029125A1 HK 00108461 A HK00108461 A HK 00108461A HK 00108461 A HK00108461 A HK 00108461A HK 1029125 A1 HK1029125 A1 HK 1029125A1
Authority
HK
Hong Kong
Prior art keywords
dolastatin
derivatives
Prior art date
Application number
HK00108461A
Other languages
English (en)
Inventor
Bernd Janssen
Teresa Barlozzari
Andreas Haupt
Thomas Zierke
Andreas Kling
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of HK1029125A1 publication Critical patent/HK1029125A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK00108461A 1997-07-18 2000-12-28 Dolastatin 15 derivatives HK1029125A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/896,394 US6143721A (en) 1997-07-18 1997-07-18 Dolastatin 15 derivatives
PCT/US1998/013901 WO1999003879A1 (en) 1997-07-18 1998-07-07 Dolastatin 15 derivatives

Publications (1)

Publication Number Publication Date
HK1029125A1 true HK1029125A1 (en) 2001-03-23

Family

ID=25406130

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108461A HK1029125A1 (en) 1997-07-18 2000-12-28 Dolastatin 15 derivatives

Country Status (33)

Country Link
US (6) US6143721A (hu)
EP (1) EP0991658B1 (hu)
JP (4) JP4508413B2 (hu)
KR (1) KR100579748B1 (hu)
CN (1) CN1268636C (hu)
AR (1) AR018501A1 (hu)
AT (1) ATE314387T1 (hu)
AU (1) AU750120B2 (hu)
BG (1) BG65212B1 (hu)
BR (1) BR9810911A (hu)
CA (1) CA2296036C (hu)
CO (1) CO4990967A1 (hu)
CY (1) CY1107047T1 (hu)
CZ (1) CZ303045B6 (hu)
DE (1) DE69832982T2 (hu)
DK (1) DK0991658T3 (hu)
ES (1) ES2258819T3 (hu)
HK (1) HK1029125A1 (hu)
HR (1) HRP980397A2 (hu)
HU (1) HU228996B1 (hu)
ID (1) ID24669A (hu)
IL (1) IL133784A (hu)
MY (1) MY135057A (hu)
NO (1) NO326827B1 (hu)
NZ (1) NZ502296A (hu)
PL (1) PL197884B1 (hu)
PT (1) PT991658E (hu)
RU (1) RU2195462C2 (hu)
SK (1) SK286581B6 (hu)
TR (2) TR200103545T2 (hu)
TW (1) TW533217B (hu)
WO (1) WO1999003879A1 (hu)
ZA (1) ZA986358B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
WO2001058928A1 (en) * 2000-02-08 2001-08-16 Nagasawa Herbert T N-terminal d(-)-penicillamine peptides as aldehyde sequestration agents
US7256257B2 (en) * 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
IL163868A0 (en) 2002-03-22 2005-12-18 Eisai Co Ltd Hermiasterlin derivatives and uses thereof
ES2556641T3 (es) * 2002-07-31 2016-01-19 Seattle Genetics, Inc. Conjugados de fármacos y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa
KR101438983B1 (ko) 2003-11-06 2014-09-05 시애틀 지네틱스, 인크. 리간드에 접합될 수 있는 모노메틸발린 화합물
US20060148014A1 (en) * 2004-12-09 2006-07-06 Sergei Agoulnik Tubulin isotype screening in cancer therapy using hemiasterlin analogs
EP1883627B1 (en) 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
PT2176296E (pt) 2007-07-16 2012-05-14 Genentech Inc Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
JP2010533495A (ja) 2007-07-16 2010-10-28 ジェネンテック， インコーポレイテッド ヒト化ＣＤ７９ｂ抗体およびイムノコンジュゲートならびにそれらの使用
DE102007039706A1 (de) 2007-08-22 2009-02-26 Erhard Prof. Dr.-Ing. Kohn Chemischer Sensor auf Diamantschichten
MY157403A (en) 2008-01-31 2016-06-15 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
CA2784748A1 (en) 2009-12-18 2011-06-23 Idenix Pharmaceuticals, Inc. 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
MX341687B (es) 2010-02-10 2016-08-30 Immunogen Inc "anticuerpos cd20 y su utilización".
ES2625637T3 (es) 2010-02-12 2017-07-20 Pharmascience Inc. Compuestos de unión al dominio BIR IAP
EP2922818B1 (en) 2012-11-24 2018-09-05 Hangzhou Dac Biotech Co., Ltd Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
CA3069221C (en) 2014-09-23 2023-04-04 Genentech, Inc. Methods of using anti-cd79b immunoconjugates
AU2015242213A1 (en) 2015-07-12 2018-03-08 Hangzhou Dac Biotech Co., Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN110099682B (zh) 2016-11-14 2023-03-31 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
AU2022338463A1 (en) 2021-09-03 2024-03-21 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
US5533097A (en) * 1992-02-26 1996-07-02 Motorola, Inc. Portable communication system comprising a local and wide area communication units which can store a communication when the wide area communication system is not available
WO1993017388A1 (en) * 1992-02-26 1993-09-02 Clark Paul C System for protecting computers via intelligent tokens or smart cards
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
AU669710B2 (en) * 1992-05-20 1996-06-20 Abbott Gmbh & Co. Kg Derivatives of dolastatin
ATE196296T1 (de) * 1992-12-16 2000-09-15 Basf Ag Dolastatin analog
US5554993A (en) * 1994-01-04 1996-09-10 Panasonic Technologies, Inc. Global position determining system and method
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5554725A (en) * 1994-09-14 1996-09-10 Arizona Board Of Regents Acting On Behalf Of Arizona State University Synthesis of dolastatin 15
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5618232A (en) * 1995-03-23 1997-04-08 Martin; John R. Dual mode gaming device methods and systems
US5970143A (en) * 1995-11-22 1999-10-19 Walker Asset Management Lp Remote-auditing of computer generated outcomes, authenticated billing and access control, and software metering system using cryptographic and other protocols
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
CA2287379C (en) * 1997-01-10 2005-10-04 Silicon Gaming-Nevada Method and apparatus for providing authenticated, secure on-line communication between remote locations
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6554705B1 (en) * 1997-08-22 2003-04-29 Blake Cumbers Passive biometric customer identification and tracking system
US6629591B1 (en) * 2001-01-12 2003-10-07 Igt Smart token
US6438382B1 (en) * 2001-02-14 2002-08-20 Telefonaktiebolaget Lm Ericsson (Publ.) Expedited location determination in analog service areas

Also Published As

Publication number Publication date
TR200000132T2 (tr) 2000-05-22
US6458765B1 (en) 2002-10-01
AU8475898A (en) 1999-02-10
DE69832982D1 (de) 2006-02-02
JP2001515010A (ja) 2001-09-18
DE69832982T2 (de) 2006-08-24
US7084110B2 (en) 2006-08-01
BG104089A (en) 2000-12-29
US8163698B2 (en) 2012-04-24
IL133784A0 (en) 2001-04-30
US6143721A (en) 2000-11-07
CZ2000176A3 (en) 2001-06-13
US20030153505A1 (en) 2003-08-14
WO1999003879A1 (en) 1999-01-28
JP2009137967A (ja) 2009-06-25
HUP0004234A3 (en) 2001-08-28
HUP0004234A2 (hu) 2001-05-28
PL338144A1 (en) 2000-09-25
US20100099843A1 (en) 2010-04-22
EP0991658B1 (en) 2005-12-28
JP5122429B2 (ja) 2013-01-16
KR100579748B1 (ko) 2006-05-15
IL133784A (en) 2005-09-25
JP5047935B2 (ja) 2012-10-10
NO20000231D0 (no) 2000-01-17
ZA986358B (en) 2000-01-17
PT991658E (pt) 2006-05-31
DK0991658T3 (da) 2006-05-15
TR200103545T2 (tr) 2002-06-21
JP4508413B2 (ja) 2010-07-21
JP2012211164A (ja) 2012-11-01
BR9810911A (pt) 2000-08-01
CZ303045B6 (cs) 2012-03-07
HU228996B1 (hu) 2013-07-29
CN1264388A (zh) 2000-08-23
CA2296036C (en) 2007-05-01
ES2258819T3 (es) 2006-09-01
NO20000231L (no) 2000-01-17
CA2296036A1 (en) 1999-01-28
SK187999A3 (en) 2000-09-12
AU750120B2 (en) 2002-07-11
RU2195462C2 (ru) 2002-12-27
CO4990967A1 (es) 2000-12-26
HRP980397A2 (en) 1999-04-30
NZ502296A (en) 2002-02-01
BG65212B1 (bg) 2007-07-31
PL197884B1 (pl) 2008-05-30
EP0991658A1 (en) 2000-04-12
JP2009137968A (ja) 2009-06-25
US20130046077A1 (en) 2013-02-21
AR018501A1 (es) 2001-11-28
US20060270606A1 (en) 2006-11-30
SK286581B6 (sk) 2009-01-07
ID24669A (id) 2000-07-27
TW533217B (en) 2003-05-21
US7662786B2 (en) 2010-02-16
NO326827B1 (no) 2009-02-23
ATE314387T1 (de) 2006-01-15
CN1268636C (zh) 2006-08-09
MY135057A (en) 2008-01-31
CY1107047T1 (el) 2012-09-26
KR20010021998A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
HUP0103560A3 (en) Dolastatin 15 derivatives
HK1029125A1 (en) Dolastatin 15 derivatives
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
ZA955784B (en) Amino purine-beta-D-ribofuranuronamide derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
HU9801168D0 (en) Triazinylaminostilbene derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9508453D0 (en) Type 120
EP0850950A4 (en) PEPTIDE DERIVATIVES
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
EP0861849A4 (en) PEPTIDE DERIVATIVES
GB9723845D0 (en) 6568471001
SI0991658T1 (sl) Derivati dolastatina 15
GB9825420D0 (en) 755273001
IL129029A0 (en) 8(9)-Dehydroestradiol derivatives
EP0862626A4 (en) PILOSULIN 2
AU942P (en) WOORIKEE 2000 Isopogon anemonifolius
GB9723437D0 (en) Farysoft 2000
GB9722157D0 (en) Bastlock 2000
GB9706753D0 (en) Aralkoxy-morphinan derivatives
GB9610406D0 (en) Envirofoam 2000
GB9615974D0 (en) Colorbox 2000

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130707